Fax completed prior authorization request form to 800-854-7614 or submit Electronic Prior Authorization through
CoverMyMeds® or SureScripts.
All requested data must be provided. Incomplete forms or forms without the chart notes will be returned
Pharmacy Coverage Guidelines are available at www.mercycareaz.org/providers/completecare-
forproviders/pharmacy
Xolair
Pharmacy Prior Authorization Request Form
Do not copy for future use. Forms are updated frequently.
REQUIRED: Office notes, labs
, and medical testing relevant to request showing medical justification are required to support
diagnosis
Member Information
Member Name (first & last):
Member ID: City: State: Weight:
Prescribing Provider Information
Provider Name (first & last): Specialty: NPI# DEA#
Dispensing Pharmacy Information
Requested Medication Information
What medication(s) has member tried and failed for this diagnosis?
Please specify:
Medication request is NOT for an FDA- approved, or
compendia-supported diagnosis (circle one):
Yes No
Diagnosis: ICD-10 Code:
Are there any contraindications to formulary medications?
Yes No
If y
es, please specify:
Direct
ions for Us
e: Strength: Dosage Form:
Quantity: Day Supply: Duration of Therapy/Use:
Turn-Around Time for Review
Standard – (24 hours) Urgent – waiting 24 hours for a standard decision could seriously harm life,
health, or ability to regain maximum function, you can ask for an expedited
decision.
Signature: ____
_________________________________________________
Moderate to Severe Persistent Asthma
Does member have a positive skin test OR in-
vitro reactivity to perennial allergen (dust mite,
animal dander, cockroach, etc.)?
Is immunoglobulin E (IgE) between 30
and 1300 IU/mL?
Has member been compliant with medium to high dose ICS + LABA for 3 months OR other controller
medications (LTRA or theophylline), if intolerant to LABA?
Yes No
Asthma symptoms are poorly controlled
on 1 of above regimens as defined by ANY
of the following:
rescue
medications
occurring more than
once per week
At least 2 exacerbations in last 12
months requiring additional
medical treatment (systemic
corticosteroids, ER visits or
Effective: 06/28/2021 C7838-A 01-2021 Page 1 of 2
click to sign
signature
click to edit